Vanguard Capital Management’s MBX Biosciences MBX Stock Holding History
Bought
Maintained
Sold
Other funds holding MBX
Vanguard Capital Management's MBX Position: Q3 2026 in Review
Vanguard Capital Management reduced its MBX Biosciences (MBX) stake by 3.1% in Q3 2026, selling an estimated $2.91M and leaving 1,430,897 shares worth $83.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1626.
Vanguard Capital Management first reported a position in MBX in Q1 2026 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold MBX as of Q3 2026.
- Vanguard Capital Management held 1,430,897 shares of MBX Biosciences worth $83.9M as of Q3 2026.
- Vanguard Capital Management sold 46,491 MBX Biosciences shares in Q3 2026, an estimated $2.91M.
- MBX Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1626 holding.
- Vanguard Capital Management first reported a position in MBX Biosciences in Q1 2026 and has held it in 3 quarters since.
- 190 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.